Middle East and Africa Laboratory Developed Test Market Overview and Growth by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Middle East and Africa Laboratory Developed Test Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Clinical Biochemistry, Critical Care, Haematology, Microbiology, Molecular Diagnostics, Immunology, and Other Test Types) and Application (Academic Institutes, Clinical Research Organizations, Hospitals Laboratory, Specialty Diagnostic Centers, and Others)

  • Report Code : TIPRE00025909
  • Category : Life Sciences
  • No. of Pages : 109
Buy Now

The Middle East and Africa laboratory developed test market is expected to reach US$ 869.59 million by 2028 from US$ 577.05 million in 2021; it is estimated to grow at a CAGR of 7.0% from 2021to 2028.

The continuous research on personalized medicine and rising automation of laboratory processes across the globe are factors propelling the laboratory developed testing market. However, the changing regulatory landscape is hampering the growth of the Middle East and Africa laboratory development test market.

LDTs play a vital role in developing personalized medicines that are likely to prove as promising means of tackling diseases through far eluded effective treatments or cures. As per the Personalized Medicine Coalition, personalized medicines accounted for only 5% of the new FDA-approved molecular entities in 2005; however, in 2016, this number rose to more than 25%. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to serve as personalized medicines. Biopharmaceutical companies have nearly doubled their R&D investments in personalized drugs in the last five years across the globe. They are further expected to increase their investments by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines in the next five years. Personalized medicines are becoming the trademark of cancer treatment; it is a constantly emerging approach based on the customization of treatments per the individual genetic structure. In 2019, the FDA approved 12 personalized medications to investigate and address the root causes of disease; thus, combining precision medicine in clinical care. The rising demand for personalized medicine is, therefore, offering significant growth opportunities for the players operating in the MEA laboratory developed test market. Also, automation is emerging as an approach to minimize human involvement in laboratory processes boosting market growth.

Economic uncertainties and ongoing conflicts are worsening the condition in the Middle East. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and are unable to implement any public health measures. A sudden drop in domestic and external demand for goods and products, especially crude oil, and halted production due to labor shortage are significant impacts observed in the region. Additionally, tightened financial condition is decreasing the economic activities in Middle East. Thus, negatively impacting the growth of the laboratory developed test in the region.

 Middle East and Africa Laboratory Developed Test Market
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

MIDDLE EAST AND AFRICA LABORATORY DEVELOPED TEST MARKET SEGMENTATION

By Type

  • Clinical Biochemistry
  • Critical Care
  • Haematology
    • Coagulation and Hemostasis,
    • Hemoglobin Testing
    • Blood Count Testing
    • Others
  • Immunology
  • Microbiology
  • Molecular Diagnostics
  • Other Test Types

By Application

  • Academic Institutes
  • Clinical Research organizations
  • Hospitals laboratory
  • Specialty Diagnostic Centers
  • Others

By Country

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

Company Profiles

  • Quest Diagnostics Incorporated
  • F. HOFFMANN-LA ROCHE LTD.
  • QIAGEN
  • Illumina, Inc.
  • Rosetta Genomics Ltd.

Middle East and Africa Laboratory Developed Test Report Scope

Report Attribute Details
Market size in 2021 US$ 577.05 Million
Market Size by 2028 US$ 869.59 Million
Global CAGR (2021 - 2028) 7.0%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Clinical Biochemistry
  • Critical Care
  • Haematology
  • Microbiology
  • Molecular Diagnostics
  • Immunology
  • Other Test Types
By Application
  • Academic Institutes
  • Clinical Research Organizations
  • Hospitals Laboratory
  • Specialty Diagnostic Centers
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Quest Diagnostics Incorporated
  • F. HOFFMANN-LA ROCHE LTD.
  • QIAGEN
  • Illumina, Inc.
  • Rosetta Genomics Ltd.
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    middle-east-and-africa-laboratory-developed-test-market-report-deliverables-img1
    middle-east-and-africa-laboratory-developed-test-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    Middle East and Africa Laboratory Developed Test Market
    Connect With Expert
    1. Quest Diagnostics Incorporated
    2. F. HOFFMANN-LA ROCHE LTD.
    3. QIAGEN
    4. Illumina, Inc.
    5. Rosetta Genomics Ltd.
    middle-east-and-africa-laboratory-developed-test-market-cagr